MISSOULA, Mont., Dec. 23, 2024 /PRNewswire/ -- Pathlabs, a leading Media Execution Partner (MEP) specializing in end-to-end digital media solutions for agencies, is pleased to announce the appointment ...

When your lawn needs mowing, sometimes you buy a lawn mower, and sometimes you hire someone to mow it for you. In the media agency world, Pathlabs is that hired hand, according to Mario Schulzke, COO ...

NEW YORK--(BUSINESS WIRE)--Global programmatic media partner MiQ today announced plans to acquire Pathlabs, the Media Execution Partner (MEP) that provides end-to-end digital media execution services ...

Dr Lal PathLabs Q3 results date: Diagnostics company Dr Lal PathLabs is slated to meet next to consider and approve its financial results for the quarter ended December 30, 2024 (Q3), the company ...

Emkay Global Financial is bullish on Dr Lal Pathlabs has recommended buy rating on the stock with a target price of Rs 1740 in its research report dated May 01, 2026. The balance sheet gives him room ...

Dr Lal PathLabs share price today: Diagnostics company Dr Lal PathLabs rose as much as 8.18 per cent to the day's high of Rs 2,540 on NSE in morning deals. Dr Lal PathLabs share price target: Dr Lal ...

Dr Lal PathLabs Q4 Results: New Delhi-headquartered Dr Lal PathLabs reported a 49 per cent year-on-year jump in consolidated net profit to Rs 84.5 crore for the March quarter. Its quarterly revenue ...

Shares of Dr Lal PathLabs soared over 8 percent in early trade on May 13 as the company's upbeat management commentary and a solid earnings performance in the March quarter fanned hopes of strong ...